Replies to post #10207 on US Stem Cell Inc (USRM)

[BluSkies]

BHRT has been in business for over 14 years. Product revenues during the first quarter of 2014 were $322,572!

[BluSkies]

PHASE I ANGEL Trial ~The six month data has far exceeded our expectations. We were excited to see that patients continued to improve from 3 months to 6 months demonstrating the power of a biological product which can actually remodel tissue and change the course of a disease,” said Kristin Comella, Bioheart’s Chief Science Officer. This phase I study will provide necessary safety and preliminary efficacy of adipose derived stem cells (AdipoCellTM) in patients with congestive heart failure. Endpoints include safety, exercise capacity, quality of life, and ejection fraction at 3 months, 6 months and 12 months.

[pijoe]

One of the worst ipos? Thats not even close to an accurate statement. ie see GNTA.... see MCET.. there are thousands ipon thousands of penny stocks without 1/2 the pipeline of bhrt trying/have tried to make it and filing bankrupt or are a fake shell trying to steal money. There is a reason why they are penny stocks. This is common sense.......

[Tru_Nort]

Thanks for your in depth DD Hopalongstocks, I am considering taking a position in BHRT, but I want to learn more about their future financing plans. I see great potential here but it seems they need to get their financial act together without ruining shareholder value with dilution or toxic financing. Hopefully they announce a partnership or merger. Also they need to get clinical trials up and running again. Seems the trials are on hold, not completed or not yet recruting with no updated info. Links below....

http://www.clinicaltrials.gov/ct2/results?term=MyoCell&Search=Search